Circulating microRNAs can be used as biomarkers for genetic generalized epilepsies

Takeaway

  • Circulating microRNAs, particularly miR-146a and miR-155, could act as biomarkers for genetic generalized epilepsies.

Why this matters

    MicroRNA stability in serum makes them attractive candidates for biomarkers; using these circulating microRNAs as biomarkers for genetic generalized epilepsies could improve diagnosis and prognosis, as well as identify new treatment targets.